Understand the source comparison
The Two-Phase Storage Protocol: Lyophilised vs Reconstituted LL-37
LL-37 need refrigeration storage at different temperatures depending on whether the peptide is in lyophilised (freeze-dried powder) or reconstituted (mixed with bacteriostatic water) form. These are not interchangeable conditions. Each phase has a specific tem
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- LL-37 need refrigeration storage at different temperatures depending on whether the peptide is in lyophilised (freeze-dried powder) or reconstituted (mixed with bacteriostatic water) form. These are not interchangeable conditions. Each phase has a specific temperature requirement dictated by the peptide's physical state and the degradation pathways active at that state.
- Lyophilised LL-37 storage (before reconstitution): Store at −20°C in a standard freezer. Lyophilised peptides are essentially dehydrated. The freeze-drying process removes water under vacuum, leaving the peptide in a glassy solid state with less than 2% residual moisture. In this state, peptide bond hydrolysis cannot occur because there are no free water molecules to participate in the reaction. The primary degradation pathway for lyophilised LL-37 is oxidation of methionine residues by atmospheric oxygen that penetrates the vial seal over time. Freezing at −20°C reduces the kinetic energy of oxygen molecules and slows diffusion through the stopper by a factor of 20–30 compared to room temperature. Lyophilised LL-37 stored at −20°C retains more than 95% potency for 18–24 months; the same peptide stored at 4°C degrades to 70–80% potency within 6 months.
- Critical point: do not store lyophilised LL-37 in a frost-free freezer. Frost-free units cycle temperature every 8–12 hours to prevent ice buildup, and these temperature swings. Even within the −15°C to −25°C range. Cause micro-condensation on the peptide powder, introducing the water needed for hydrolysis. Use a manual-defrost freezer or a dedicated laboratory freezer with stable temperature control.
- Reconstituted LL-37 storage (after mixing with bacteriostatic water): Store at 2–8°C in the main compartment of a refrigerator. Never the door, which experiences temperature fluctuations every time the door opens. Once LL-37 is reconstituted, it exists in aqueous solution, and water-mediated degradation pathways become active. Peptide bond hydrolysis proceeds at a rate proportional to temperature. At 25°C, the half-life of reconstituted LL-37 is approximately 7–10 days; at 4°C, it extends to 35–40 days. The standard 28-day use window is a conservative threshold that ensures potency remains above 90% throughout the usage period.
- Refrigeration also prevents microbial growth in the bacteriostatic water. Bacteriostatic water contains 0.9% benzyl alcohol, which inhibits bacterial reproduction but does not sterilise the solution. At temperatures above 15°C, bacterial contamination can occur despite the benzyl alcohol, particularly after multiple needle punctures introduce airborne microbes. We've seen contaminated vials in research settings where the peptide was stored at 10–12°C. Just outside the safe range. The contamination isn't always visible. Turbidity or color change may not appear until bacterial density exceeds 10^6 CFU/mL, by which point the peptide has been exposed to bacterial enzymes that cleave peptide bonds indiscriminately.
- LL-37 need refrigeration storage in both phases, but the lyophilised phase is more forgiving. A single temperature excursion during shipping (e.g., 6 hours at 25°C) causes minimal damage to lyophilised powder but can destroy 30–50% of reconstituted peptide activity. This is why we ship lyophilised LL-37 with cold packs and temperature monitors, and we instruct researchers to refrigerate immediately upon receipt and reconstitute only the amount they'll use within the 28-day window.